Key Takeaways
- • Pegasus Tech Ventures and CYBERDYNE, Inc. launched a JPY 10 billion (approximately US $60M) corporate venture capital fund to back startups in robotics, Physical AI, healthcare, automation, and intelligent systems, according to a Business Wire release dated June 16, 2026.
- • Pegasus Tech Ventures acts as General Partner of the fund, while CYBERDYNE is the sole Limited Partner, giving the Japanese company access to Pegasus's Silicon Valley and global innovation network through its Venture Capital-as-a-Service (VCaaS) platform.
- • The fund's investment thesis centers on CYBERDYNE's "HCPS Cybernics with Physical AI" framework, which fuses humans, AI-robotics and information systems across the Human-Cyber-Physical Space.
- • The fund targets aging populations, workforce shortages, and rising healthcare demand, areas where CYBERDYNE's HAL wearable device is already deployed in Japan and overseas.
Summary
Pegasus Tech Ventures, a Silicon Valley-based venture capital firm and provider of Venture Capital-as-a-Service solutions, has launched a JPY 10 billion (US $60M) corporate venture capital (CVC) fund in partnership with CYBERDYNE, Inc., according to a Business Wire announcement. Pegasus serves as General Partner of the fund, and CYBERDYNE participates as its sole Limited Partner.
The fund will invest in startups developing technologies across robotics, Physical AI, healthcare, automation, and intelligent systems. Its stated focus is advancing CYBERDYNE's vision of HCPS Cybernics with Physical AI, which combines bio/medical systems, AI-robotics and information systems within the Human-Cyber-Physical Space. Through Pegasus's VCaaS platform and its network of startups, investors and corporate partners, the partners aim to accelerate strategic investments, technology partnerships and new business opportunities.
CYBERDYNE was founded in 2004 by Professor Yoshiyuki Sankai of the University of Tsukuba. Its flagship product, the HAL wearable cyborg device, is designed to assist, enhance, improve and regenerate human physical functions by detecting bioelectric signals from the wearer, and it has been widely adopted in Japan and overseas, particularly in medical and healthcare settings. The company describes two business initiatives: Cybernics Medical and Healthcare Innovation, which connects hospitals, homes and workplaces through AI-driven analysis and data integration, and Cybernics Life Innovation, which applies AI-enabled control and assistance technologies to mobility, logistics and work activities.
Sankai, Founder and CEO of CYBERDYNE, said the company is committed to creating new value by fusing humans, AI-robotics and information systems, and expects the Pegasus partnership to accelerate technology development, business co-creation and global expansion. Dr. Anis Uzzaman, Founder and CEO of Pegasus Tech Ventures, said the VCaaS platform would connect CYBERDYNE with entrepreneurs, breakthrough technologies and strategic opportunities from Silicon Valley and other innovation ecosystems.
Pegasus describes itself as managing more than 40 funds and over USD $2 billion in assets, with more than 300 startup investments globally. The release does not disclose the fund's closing date, investment targets per company, or fund vintage terms.
The fund will invest in startups developing technologies across robotics, Physical AI, healthcare, automation, and intelligent systems. Its stated focus is advancing CYBERDYNE's vision of HCPS Cybernics with Physical AI, which combines bio/medical systems, AI-robotics and information systems within the Human-Cyber-Physical Space. Through Pegasus's VCaaS platform and its network of startups, investors and corporate partners, the partners aim to accelerate strategic investments, technology partnerships and new business opportunities.
CYBERDYNE was founded in 2004 by Professor Yoshiyuki Sankai of the University of Tsukuba. Its flagship product, the HAL wearable cyborg device, is designed to assist, enhance, improve and regenerate human physical functions by detecting bioelectric signals from the wearer, and it has been widely adopted in Japan and overseas, particularly in medical and healthcare settings. The company describes two business initiatives: Cybernics Medical and Healthcare Innovation, which connects hospitals, homes and workplaces through AI-driven analysis and data integration, and Cybernics Life Innovation, which applies AI-enabled control and assistance technologies to mobility, logistics and work activities.
Sankai, Founder and CEO of CYBERDYNE, said the company is committed to creating new value by fusing humans, AI-robotics and information systems, and expects the Pegasus partnership to accelerate technology development, business co-creation and global expansion. Dr. Anis Uzzaman, Founder and CEO of Pegasus Tech Ventures, said the VCaaS platform would connect CYBERDYNE with entrepreneurs, breakthrough technologies and strategic opportunities from Silicon Valley and other innovation ecosystems.
Pegasus describes itself as managing more than 40 funds and over USD $2 billion in assets, with more than 300 startup investments globally. The release does not disclose the fund's closing date, investment targets per company, or fund vintage terms.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.